Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) - Total Liabilities
Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has total liabilities worth CN¥321.96 Million CNY (≈ $47.11 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Zhejiang Cheng Yi Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Zhejiang Cheng Yi Pharmaceutical Co Ltd - Total Liabilities Trend (2011–2025)
This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 603811 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
KKR Credit Income Fund
AU:KKC
|
Australia | AU$27.15 Million |
|
Gallant Precision Machining Co Ltd
TWO:5443
|
Taiwan | NT$6.89 Billion |
|
MN Holdings Berhad
KLSE:0245
|
Malaysia | RM252.70 Million |
|
Wild Bunch AG
F:WBAH
|
Germany | €190.14 Million |
|
Pangaea Logistic
NASDAQ:PANL
|
USA | $466.59 Million |
|
Jiangsu Rijiu Optoelectronics Joint
SHE:003015
|
China | CN¥158.03 Million |
|
ACNB Corporation
NASDAQ:ACNB
|
USA | $2.81 Billion |
|
VIP Industries Limited
NSE:VIPIND
|
India | Rs12.58 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Zhejiang Cheng Yi Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang Cheng Yi Pharmaceutical Co Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Cheng Yi Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)
The table below shows the annual total liabilities of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥304.55 Million ≈ $44.57 Million |
-34.27% |
| 2024-12-31 | CN¥463.31 Million ≈ $67.80 Million |
-33.45% |
| 2023-12-31 | CN¥696.15 Million ≈ $101.87 Million |
+10.82% |
| 2022-12-31 | CN¥628.16 Million ≈ $91.92 Million |
+94.11% |
| 2021-12-31 | CN¥323.62 Million ≈ $47.36 Million |
+0.88% |
| 2020-12-31 | CN¥320.79 Million ≈ $46.94 Million |
+51.83% |
| 2019-12-31 | CN¥211.29 Million ≈ $30.92 Million |
+48.33% |
| 2018-12-31 | CN¥142.45 Million ≈ $20.84 Million |
+94.04% |
| 2017-12-31 | CN¥73.41 Million ≈ $10.74 Million |
-12.72% |
| 2016-12-31 | CN¥84.11 Million ≈ $12.31 Million |
-2.44% |
| 2015-12-31 | CN¥86.21 Million ≈ $12.62 Million |
+4.16% |
| 2014-12-31 | CN¥82.77 Million ≈ $12.11 Million |
-37.50% |
| 2013-12-31 | CN¥132.43 Million ≈ $19.38 Million |
-26.42% |
| 2012-12-31 | CN¥179.99 Million ≈ $26.34 Million |
-6.78% |
| 2011-12-31 | CN¥193.09 Million ≈ $28.25 Million |
-- |
About Zhejiang Cheng Yi Pharmaceutical Co Ltd
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of formulations and active pharmaceutical ingredients in China and internationally. The company offers glucosamine hydrochloride raw materials and preparations, gastrodin raw materials, ribavirin preparations raw materials, and sulfur dioxide raw materials. It also provides injections, food, cap… Read more